Race to market custom-made cancer therapies hits roadblocks
Hurdles abound in race to bring customized cancer treatments to masses
September Two, 2016
he idea is tantalizing: Reengineer a patient’s own immune cells to attack the cancer that’s killing her. Scientists have proven it can be done, curing patients of otherwise terminal blood cancers.
But faith in this treatment, dubbed CAR-T immunotherapy, has been shaken in latest months. …